Definitive Healthcare (NASDAQ:DH) Updates FY24 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.36-$0.38 for the period, compared to the consensus earnings per share estimate of $0.38. The company issued revenue guidance of $255-261 million, compared to the consensus revenue estimate of $266.31 million. Definitive Healthcare also updated its Q2 guidance to $0.08-$0.09 EPS.

Analyst Ratings Changes

A number of equities research analysts have issued reports on DH shares. Barclays boosted their price target on Definitive Healthcare from $10.00 to $11.00 and gave the company an equal weight rating in a research report on Friday, March 1st. Canaccord Genuity Group boosted their target price on Definitive Healthcare from $9.00 to $10.00 and gave the stock a hold rating in a report on Thursday, February 29th. Stifel Nicolaus cut their price target on shares of Definitive Healthcare from $12.00 to $11.00 and set a buy rating on the stock in a report on Wednesday, January 17th. Finally, Needham & Company LLC downgraded shares of Definitive Healthcare from a buy rating to a hold rating in a research note on Wednesday, January 17th. Seven research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, Definitive Healthcare currently has a consensus rating of Hold and a consensus price target of $11.31.

Definitive Healthcare Stock Down 1.2 %

Shares of DH stock traded down $0.09 during trading hours on Tuesday, reaching $7.25. The company had a trading volume of 480,437 shares, compared to its average volume of 560,899. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. Definitive Healthcare has a twelve month low of $5.53 and a twelve month high of $12.45. The company has a market capitalization of $853.98 million, a P/E ratio of -4.07, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41. The stock’s fifty day simple moving average is $7.82 and its 200 day simple moving average is $8.31.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The company had revenue of $65.93 million during the quarter, compared to analyst estimates of $66.01 million. As a group, sell-side analysts expect that Definitive Healthcare will post 0.11 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.